Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

4.97
Delayed Data
As of 3:59pm ET
 -0.10 / -1.97%
Today’s Change
2.47
Today|||52-Week Range
9.24
+39.83%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close5.07
Today’s open5.09
Day’s range4.92 - 5.15
Volume37,236
Average volume (3 months)252,839
Market cap$56.0M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+15.38%
Earnings growth (this year)-1,061.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+55.96%
P/E ratioNM
Price/Sales1,825.89
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
BPMXBiopharmx Corp-0.08-10.12%
ADMAADMA Biologics Inc+0.09+2.03%
COOLPolarityte Inc-0.78-6.54%
KMPHKemPharm Inc+0.16+3.83%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$6.76
Annual revenue (last year)$16.2K
Annual profit (last year)-$21.1M
Net profit margin-129,721.85%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Richard J. Daly
Chief Financial Officer
Jonathan B. Lloyd Jones
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs